Saliva from cystic fibrosis patients contains an unusual form of epidermal growth factor.
Epidermal Growth Factor (EGF) was assayed in saliva collected from control subjects and cystic fibrosis (CF) patients, using both radioimmuno (RIA) and radioreceptor (RRA) assays. An intriguing finding was that the average ratio of the values found by RRA over those obtained by RIA was of 1.7 for normal subjects and of about 0.4 for CF patients. This observation could be understood following gel filtration analysis of EGF-like material in these salivary fluids. Whereas control saliva contained the expected 6 kDa EGF active peptide, the immunoreactive EGF material from CF patients eluted as a polydisperse macromolecular moiety. The poor biological reactivity of this material as assessed by radioreceptor assay suggests that this EGF anomaly may contribute to the physiopathology of cystic fibrosis, especially as the upper gastrointestinal tract differentiated functions may be the target of normal salivary EGF.
Aubert
B
B
Unité INSERM 244, BRCE, LBIO, DBMS, Centre d'Etudes Nucléaires, 85X, Grenoble, France.
Cochet
C
C
Souvignet
C
C
Chambaz
E M
EM
D000293:Adolescent; D002648:Child; D002850:Chromatography, Gel; D003550:Cystic Fibrosis / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000032:analysis*; D006801:Humans; D011863:Radioimmunoassay; D011869:Radioligand Assay; D012463:Saliva / Q000032:analysis*
D004815:Epidermal Growth Factor